Dianthus Therapeutics, INC. /De/ (DNTH) SEC Filings — 2024
28 SEC filings for Dianthus Therapeutics, INC. /De/ (DNTH) in 2024.
Filings
- Dianthus Therapeutics Files 8-K — 8-K · Dec 12, 2024
- Avidity Partners Amends Stake in Dianthus Therapeutics — SC 13D/A · Dec 3, 2024
- Dianthus Therapeutics, INC. /De/ SC 13G Filing — SC 13G · Nov 22, 2024
- Dianthus Therapeutics, INC. /De/ SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Dianthus Therapeutics, INC. /De/ SC 13G Filing — SC 13G · Nov 8, 2024
- Dianthus Therapeutics Q3 2024 Update — 10-Q · Nov 7, 2024
- Dianthus Therapeutics, INC. /De/ SC 13G Filing — SC 13G · Oct 24, 2024
- Dianthus Therapeutics, INC. /De/ SC 13G Filing — SC 13G · Oct 11, 2024
- Dianthus Therapeutics Appoints New Director — 8-K · Sep 16, 2024
- Viridian LLC Amends Stake in Dianthus Therapeutics — SC 13D/A · Sep 12, 2024
- Dianthus Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 8, 2024
- Dianthus Therapeutics Files 8-K for Disclosure — 8-K · Jun 6, 2024
- Dianthus Therapeutics Announces Corporate Changes — 8-K · May 28, 2024
- Dianthus Therapeutics Files 10-Q for Q1 2024 — 10-Q · May 9, 2024
- Dianthus Therapeutics Announces 2024 Annual Meeting of Stockholders on May 23 — DEF 14A · Apr 11, 2024
- Fairmount Funds Adjusts Stake in Dianthus Therapeutics — SC 13D/A · Apr 1, 2024
- Dianthus Therapeutics Files S-1/A Amendment — S-1/A · Mar 21, 2024
- Dianthus Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 21, 2024
- Dianthus Therapeutics, INC. /De/ SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Dianthus Therapeutics, INC. /De/ SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- GV 2016, L.P. Amends Dianthus Therapeutics Ownership — SC 13G/A · Feb 9, 2024
- Dianthus Therapeutics Files S-1/A Amendment — S-1/A · Feb 7, 2024
- BCLS Fund III Investments Takes 5.0% Stake in Dianthus Therapeutics — SC 13G · Feb 2, 2024
- RA Capital Discloses Significant Stake in Dianthus Therapeutics — SC 13G · Feb 2, 2024
- Avidity Partners Takes 5.1% Stake in Dianthus Therapeutics — SC 13D · Jan 31, 2024
- Fairmount Funds Management Amends 13D for Dianthus Therapeutics — SC 13D/A · Jan 24, 2024
- Dianthus Therapeutics Reports Material Agreement, Unregistered Equity Sales — 8-K · Jan 22, 2024
- Dianthus Therapeutics Relocates HQ to NYC, Updates Phone — 8-K · Jan 8, 2024